Study: How do comorbidities impact joint replacement readmissions & costs?

A study published in The Journal of Arthroplasty examined how disease severity impacts 30-day readmission rates as well as costs following total joint arthroplasty.

Advertisement

Researchers identified and analyzed 2,026 TJA patients in this study.

The study found the amount and severity of co-morbid conditions strongly influences readmission rates and costs for TJA patients. Both the readmission costs and the readmission rate tended to increase with illness severity.

More articles on quality:

Nebraska Medical Center receives American Ebola patient
13 most common healthcare-associated infections
Sepsis patients fare better in hospitals with more sepsis cases

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

  • How many of you have felt like a flea in a jar? If you put fleas in a jar, they…

Advertisement

Comments are closed.